Alba Oliva-Bolarín

Mrs. Alba Oliva-Bolarín

Instituto Murciano de Investigación Biosanitaria, Murcia, Spain
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in The Journal of Pathology
Verified
Journal Article
Closed access
MSMaria Angeles Nuñez Sanchez
Maria Angeles Nuñez Sanchez
MSMaria Angeles Nuñez Sanchez
Maria Angeles Nuñez Sanchez
MSMarta Sierra‐Cruz
Marta Sierra‐Cruz
ALAna Lambertos
Ana Lambertos
SCSara Rico Chazarra
Sara Rico Chazarra
Bruno Ramos-MolinaBruno Ramos-Molina
Bruno Ramos-Molina

12 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ARAntonio J. Ruiz-Alcaraz
Antonio J. Ruiz-Alcaraz
MSMaria Angeles Nuñez Sanchez
Maria Angeles Nuñez Sanchez
MRMaría Alejandra Asensio Ruiz
María Alejandra Asensio Ruiz
MSMaria Angeles Nuñez Sanchez
Maria Angeles Nuñez Sanchez
AOAlba Oliva-Bolarín
Alba Oliva-Bolarín
Antonio Abel Lozano-PérezAntonio Abel Lozano-Pérez
Antonio Abel Lozano-Pérez
Silk fibroin nanoparticles (SFN) have become a promising tool in drug delivery systems due to their physicochemical characteristics. SFN have shown their outstanding properties as an active vehicle for polyphenols, enhancing their antioxidant and anti-inflammatory effects on macrophages; therefore, it becomes necessary to have an easy, reproducible and scalable production method. In order to improve the production of nanoparticles, we performed direct precipitation of non-dialyzed silk fibroin solutions and evaluated the reproducibility of the method using dynamic light scattering. We also studied the loading efficiency of three different natural polyphenols using propylene glycol as a solvent. The loaded nanoparticles were fully characterized and used to treat human macrophage cells to assess the anti-inflammatory activity of these nanoparticles. The measured hydrodynamic characteristics of the SFN and the overall yield of the process showed that the new preparation method is highly reproducible and repeatable. Thus, we not only present a new scalable method to prepare silk nanoparticles but also how to improve the loading of natural polyphenolic compounds to the SFN, as well as the important anti-inflammatory effects of these loaded nanoparticles in a cell model of human macrophage cells.

2 December 2022 in Food & Function
Verified
Journal Article
Open access
PDF file
PGPaula Garcia-Ibañez
Paula Garcia-Ibañez
MSMaria Angeles Nuñez Sanchez
Maria Angeles Nuñez Sanchez
AOAlba Oliva-Bolarín
Alba Oliva-Bolarín
MMMaría Antonia Martínez-Sánchez
María Antonia Martínez-Sánchez
Bruno Ramos-MolinaBruno Ramos-Molina
Bruno Ramos-Molina
Diego A. Moreno-FernandezDiego A. Moreno-Fernandez
Diego A. Moreno-Fernandez
Cruciferous vegetables have been reported to be a great source of anti-inflammatory compounds.

Verified
Journal Article
Open access
PDF file
MSMaria Angeles Nuñez Sanchez
Maria Angeles Nuñez Sanchez
MSMaria Angeles Nuñez Sanchez
Maria Angeles Nuñez Sanchez
ABAndrés Balaguer
Andrés Balaguer
AOAlba Oliva-Bolarín
Alba Oliva-Bolarín
GPGabriel Pujante-Gilabert
Gabriel Pujante-Gilabert
Bruno Ramos-MolinaBruno Ramos-Molina
Bruno Ramos-Molina
Colorectal cancer (CRC) is the third most common cancer and the second cause of cancer death worldwide. Several factors have been postulated to be involved in CRC pathophysiology, including heritable and environmental factors, which are the latest to be closely associated with nutritional habits, physical activity, obesity, and the gut microbiota. The latter may also play a key role in CRC prognosis and derived complications in patients undergoing surgery. This is a single-center, open, controlled, randomized clinical trial, in patients with scheduled surgical intervention for CRC. The primary objective is to assess whether a pre-surgical nutritional intervention, based on a high-fiber diet rich in polyunsaturated fatty acids (PUFAs), can reduce disturbances of the gut microbiota composition and, consequently, the rate of post-surgical complications in patients with CRC. Patients will be randomized in a 1:1 ratio after receiving a diagnosis of CRC. In the control arm, patients will receive standard nutritional recommendations, while patients in the intervention arm will be advised to follow a high-fiber diet rich in PUFAs before surgery. Participants will be followed up for one year to evaluate the overall rate of postsurgical complications, recurrences of CRC, response to adjuvant therapy, and overall/disease-free survival.